Preeyaporn Vichaiwattana

The Success of a Universal Hepatitis B Immunization Program as Part of Thailand’s EPI after 22 Years’ Implementation

Nawarat Posuwan, Nasamon Wanlapakorn, Pattaratida Sa‐nguanmoo et al. · PLoS ONE · 2016 · 98 citations · Full text

Thailand ’, Hepatitis B, Vaccine Hesitancy +20

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong et al. · Vaccines · 2022 · 89 citations · Full text

Detection of severe acute respiratory syndrome coronavirus 2 and influenza viruses based on CRISPR-Cas12a

Oraphan Mayuramart, Pattaraporn Nimsamer, Somruthai Rattanaburi et al. · Experimental Biology and Medicine · 2020 · 75 citations · Full text

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian et al. · Human Vaccines & Immunotherapeutics · 2022 · 66 citations · Full text

Immunology, Intermittent Supply Shortages, Vaccine Hesitancy +20

Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination

Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong et al. · The Journal of Infectious Diseases · 2022 · 61 citations